3-41220953-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001904.4(CTNNB1):c.-48-3068T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.405 in 152,016 control chromosomes in the GnomAD database, including 12,766 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.40 ( 12766 hom., cov: 32)
Exomes 𝑓: 0.50 ( 0 hom. )
Consequence
CTNNB1
NM_001904.4 intron
NM_001904.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -2.82
Publications
25 publications found
Genes affected
CTNNB1 (HGNC:2514): (catenin beta 1) The protein encoded by this gene is part of a complex of proteins that constitute adherens junctions (AJs). AJs are necessary for the creation and maintenance of epithelial cell layers by regulating cell growth and adhesion between cells. The encoded protein also anchors the actin cytoskeleton and may be responsible for transmitting the contact inhibition signal that causes cells to stop dividing once the epithelial sheet is complete. Finally, this protein binds to the product of the APC gene, which is mutated in adenomatous polyposis of the colon. Mutations in this gene are a cause of colorectal cancer (CRC), pilomatrixoma (PTR), medulloblastoma (MDB), and ovarian cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2016]
CTNNB1 Gene-Disease associations (from GenCC):
- exudative vitreoretinopathyInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
- severe intellectual disability-progressive spastic diplegia syndromeInheritance: AD, Unknown Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), Illumina, G2P, Ambry Genetics
- exudative vitreoretinopathy 7Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.451 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CTNNB1 | NM_001904.4 | c.-48-3068T>C | intron_variant | Intron 1 of 14 | ENST00000349496.11 | NP_001895.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CTNNB1 | ENST00000349496.11 | c.-48-3068T>C | intron_variant | Intron 1 of 14 | 1 | NM_001904.4 | ENSP00000344456.5 | |||
| CTNNB1 | ENST00000645982.1 | c.-48-3068T>C | intron_variant | Intron 1 of 15 | ENSP00000494845.1 | |||||
| CTNNB1 | ENST00000715152.1 | n.-48-3068T>C | intron_variant | Intron 1 of 15 | ENSP00000520353.1 |
Frequencies
GnomAD3 genomes AF: 0.405 AC: 61518AN: 151896Hom.: 12763 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
61518
AN:
151896
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.500 AC: 1AN: 2Hom.: 0 Cov.: 0 AF XY: 0.500 AC XY: 1AN XY: 2 show subpopulations
GnomAD4 exome
AF:
AC:
1
AN:
2
Hom.:
Cov.:
0
AF XY:
AC XY:
1
AN XY:
2
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
1
AN:
2
Other (OTH)
AC:
0
AN:
0
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.405 AC: 61550AN: 152014Hom.: 12766 Cov.: 32 AF XY: 0.401 AC XY: 29803AN XY: 74286 show subpopulations
GnomAD4 genome
AF:
AC:
61550
AN:
152014
Hom.:
Cov.:
32
AF XY:
AC XY:
29803
AN XY:
74286
show subpopulations
African (AFR)
AF:
AC:
14215
AN:
41464
American (AMR)
AF:
AC:
5624
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
1325
AN:
3470
East Asian (EAS)
AF:
AC:
1287
AN:
5178
South Asian (SAS)
AF:
AC:
1952
AN:
4814
European-Finnish (FIN)
AF:
AC:
4836
AN:
10528
Middle Eastern (MID)
AF:
AC:
109
AN:
294
European-Non Finnish (NFE)
AF:
AC:
30968
AN:
67962
Other (OTH)
AF:
AC:
838
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1890
3780
5671
7561
9451
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
578
1156
1734
2312
2890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1276
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.